Grifols, S.A. Market Share Analysis

GlobalData
January 25, 2013
76 Pages - SKU: GBDT4958315


Grifols, S.A. Market Share AnalysisSummary

GlobalData’s new report, “Grifols, S.A. Market Share Analysis” provides in-depth information on Grifols, S.A.’s market position in the haematology market. The report also provides data and information on the overall competitive landscape within the haematology market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Global company shares (in Revenues) information for the haematology market.
  • Grifols, S.A.’s company shares (in Revenues) information for all the key countries the company has presence in –Japan, China, Australia, France, Germany, Spain, Italy, United States and Canada.
  • Grifols, S.A.’s company shares (in Revenues) information for the haematology market.
  • All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.
  • Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
  • The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
  • Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.
Reasons to buy
  • Develop sales and marketing strategies by identifying who-stands-where in the markets, Grifols, S.A.’s operates in.
  • Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
  • Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
  • Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
  • Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Grifols, S.A.’s market positions.


Additional Information

Companies Mentioned

Sysmex Corporation
Beckman Coulter, Inc.
Siemens Healthcare
Abbott Laboratories
Horiba, Ltd.
Bio-Rad Laboratories, Inc.
Immucor, Inc.
F. Hoffmann-La Roche Ltd.
Diagnostica Stago, Inc.
Mindray Medical International Limited
Nihon Kohden Corporation
Gen-Probe Incorporated
Transasia Bio-Medicals Ltd.
Shanghai Kehua Bio-engineering Co., Ltd.
Biomedica Diagnostics Inc.
ELITech Group
Span Diagnostics Ltd.
bioMerieux S.A.
J.Mitra & Co. Pvt. Ltd.
Atlas Medical
Tulip Diagnostics (P) Ltd
Trivitron Healthcare Pvt Ltd.
BioPorto Diagnostics A/S
Diatron MI PLC

More Diagnostics Company reports by GlobalData

XEPTAGEN SpA - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryXeptagen SpA (Xeptagen) is a healthcare service provider. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening ...
Seegene, Inc. (096530) - Product Pipeline Analysis, 2014 Update by GlobalData
SummarySeegene, Inc. (Seegene) is a molecular diagnostic company. The company specializes in molecular diagnostics and develops technology and products. Its products include Anyplex II RV16 ...
Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryUniversal Biosensors, Inc. (UBI) is an Australian medical diagnostic company. The company develops and manufactures in vitro diagnostic test devices that are used for professional ...
TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryTrovaGene, Inc. (TrovaGene), formally Xenomics, Inc. is a development stage molecular diagnostic company. It develops and commercializes proprietary diagnostic technologies for screening and monitoring of ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,000  
    Site License  USD 2,000  
    Global Site License  USD 3,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!